why choose us

First received: October 25, 2022

Clinical Trial: BOTOX® vs. XEOMIN® for Chronic Migraine

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Migraine

Study Type: INTERVENTIONAL


Official Title: Single Center Study on the Sustained Effect of OnabotulinumtoxinA (BOTOX®) vs. IncobotulinumtoxinA (XEOMIN®) Botulinum Toxin in Adults With Chronic Migraine

Brief Summary: Chronic migraine (CM) is a disabling disorder that sidelines active duty personnel and diminishes their quality of life.It affects 1.3% to 2.4% of the general population.These numbers increase in active duty personnel, especially those returning from deployment, as well as in veterans.Furthermore, these numbers are 4-5 times higher in military members who experienced at least one mild traumatic brain injury.CM leads to impaired cognition and poor decision-making.These impairments on critical active duty tasks…

Read more